Wall Street had been looking for an adjusted net loss of $0.16 per share at Rapid7 during the three months ended March 31 on $154.2 million in Q1 revenue.
For the current quarter ending in June, the company is projecting an adjusted net loss of $0.07 to $0.03 per share on between $163 million to $165 million in Q2 revenue. For the full year 2022, it sees a non-GAAP profit in the range of $0.05 to $0.16 per share on $686 million to $692 million in revenue.
Analysts, on average, are modeling for an adjusted Q2 profit of $0.03 per share on $163.6 million in revenue and non-GAAP FY22 earnings of $0.11 per share on $686.6 million in revenue this year.
Rapid7 shares were more than 7% lower in extended trading, erasing a fractional advance during Wednesday's regular session.
Price: 88, Change: -6.71, Percent Change: -7.08
Insider Sell: Block |
Insider Sell: Berkshire Hathaway |
Insider Sell: Trupanion |
Insider Buy: Ikena Oncology |
Insider Sell: Apellis Pharmaceuticals |